The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Single-sample enrichment analysis identified predictive biomarker candidates for nivolumab in patients with non-small cell lung cancer.
 
Tomoiki Aiba
No Relationships to Disclose
 
Chieko Hattori
Honoraria - AstraZeneca Japan; Bristol-Myers Squibb Japan; Merck Sharp & Dohme; Ono Pharmaceutical
 
Jun Sugisaka
No Relationships to Disclose
 
Hisashi Shimizu
No Relationships to Disclose
 
Hirotaka Ono
No Relationships to Disclose
 
Yutaka Domeki
No Relationships to Disclose
 
Ryohei Saito
No Relationships to Disclose
 
Sachiko Kawana
No Relationships to Disclose
 
Yousuke Kawashima
No Relationships to Disclose
 
Keisuke Terayama
No Relationships to Disclose
 
Yukihiro Toi
Honoraria - AstraZeneca Japan; Bristol-Myers Squibb Japan; Merck Sharp & Dohme; Ono Pharmaceutical; Taiho Pharmaceutical
 
Atsushi Nakamura
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Kyowa Kirin; Lilly Japan; MSD
 
Shinsuke Yamanda
No Relationships to Disclose
 
Yuichiro Kimura
No Relationships to Disclose
 
Yutaka Suzuki
No Relationships to Disclose
 
Atsushi Niida
No Relationships to Disclose
 
Shunichi Sugawara
Honoraria - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Kyowa Kirin; Lilly; MSD K.K; Nippon Boehringer Ingelheim; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Yakult Honsha